| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |